Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Onconetix Inc ONCO

Healthcare Biotechnology
Onconetix, Inc. is a commercial stage biotechnology company. It is focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. It has Entadfi, a Food and Drug Administration approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ONCO)

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

GlobeNewswire October 3, 2024

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

GlobeNewswire October 3, 2024

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

GlobeNewswire September 20, 2024

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

GlobeNewswire July 15, 2024

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

GlobeNewswire July 11, 2024

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

GlobeNewswire February 13, 2024

Onconetix(TM) Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

GlobeNewswire December 19, 2023

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix(TM)

GlobeNewswire December 18, 2023

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

GlobeNewswire November 2, 2023
View More News ››

Opinion & Analysis (NDAQ:ONCO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ONCO)

ONCO....ripping in AH trading

Did anyone buy the reg hrs dip ?????
Iseneschal - September 26, 2024

RE:ONCO.....and now for the "blood letting"

And there you have it folks..... yesterday you witnessed the post RS Pump....and now you get the Dump.....LoL All of the Chasers...
Iseneschal - September 25, 2024

ONCO.....and now for the "blood letting"

N.L.O.D............ $3.43
Iseneschal - September 25, 2024

ONCO.....vols increased and price moved to N.H.O.D

didn't hold the gain....but I tend to think this will gap up Maybe ; )
Iseneschal - September 24, 2024

ONCO.....needs to smash thru $4.37

which was the previous H.O.D
Iseneschal - September 24, 2024

ONCO....RS this a.m

On watch ~ $4
Iseneschal - September 24, 2024
View more Bullboard ››

Leading Edge Materials Corp.

Leading Edge Materials Corp.

Leading Edge Materials Corp. is a Canada-based company focused on developing a portfolio of critical raw material projects ...
View More »